Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newer diagnostic techniques for bladder cancer.

H B Carter1, J B Amberson, N H Bander

  • 1James Buchanan Brady Foundation, Department of Surgery, New York Hospital-Cornell Medical Center, New York.

The Urologic Clinics of North America
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non-responders: Subgroup analysis of UNCOVER-3 trial.

Skin health and disease·2022
Same author

Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.

Prostate cancer and prostatic diseases·2017
Same author

Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB.J Clin Oncol. 2015 Oct 20;33(30):3379-85. [Epub 2015 Aug 31]. doi: 10.1200/JCO.2015.62.5764.

Urologic oncology·2017
Same author

Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.

Prostate cancer and prostatic diseases·2017
Same author

Round Tuberculous Infiltrates of the Lung.

The Yale journal of biology and medicine·2011
Same author

Pulmonary Tuberculosis in Young Adults, Particularly Among Medical Students and Nurses.

Transactions of the American Clinical and Climatological Association·2011
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Researchers are using immunology, cytogenetics, and molecular biology to improve bladder cancer diagnosis and treatment. Continued study aims for earlier detection, better tumor behavior prediction, and understanding cancer development.

Area of Science:

  • Urology
  • Immunology
  • Cytogenetics
  • Molecular Biology
  • Cytopathology

Background:

  • Bladder cancer presents complex challenges for urologists in patient treatment.
  • Multidisciplinary scientific approaches are crucial for advancing bladder cancer care.

Purpose of the Study:

  • To explore the application of immunology, cytogenetics, molecular biology, and cytopathology in addressing urological challenges in bladder cancer.
  • To enhance early diagnosis and improve the prediction of tumor behavior in bladder cancer patients.
  • To deepen the understanding of the molecular mechanisms underlying oncogenesis in bladder cancer.

Main Methods:

  • Application of immunological principles and techniques.

Related Experiment Videos

  • Utilization of cytogenetic analysis for chromosomal abnormalities.
  • Employing molecular biology tools for genetic and protein analysis.
  • Leveraging cytopathology for cellular-level examination of tissues.

    • Main Results:

    • Current efforts integrate diverse scientific disciplines to tackle bladder cancer patient management.
    • These integrated approaches hold promise for improving diagnostic accuracy.
    • Potential for enhanced prediction of tumor progression and patient outcomes.

    Conclusions:

    • Continued interdisciplinary research is vital for advancing bladder cancer diagnosis and treatment.
    • Further investigation will elucidate the molecular underpinnings of bladder cancer development.
    • The integration of these scientific fields is key to improving patient care and outcomes in urology.